Literature DB >> 27364960

What Scales the T Cell Response?

Viveka Mayya1, Michael L Dustin2.   

Abstract

T cells are known to scale their clonal expansion and effector cytokine response according to the dose and strength of antigenic signal so as to balance their role of affecting protection with the intertwined and immunologically driven tissue damage. How T cells achieve this is now beginning to be understood. We underscore temporal integration of digital T cell receptor (TCR) signaling as the basis for achieving scaled response by means of accumulating crucial mediators over time. We also discuss the role of temporally integrated crosstalk between TCR and IL2 signaling in mediating a scaled, coherent, collective response by T cells. Finally, we highlight numerous known and putative regulatory interactions in the transcriptional program that are expected to quantitatively scale the T cell response, and also offer new mechanisms to hitherto unexplained observations.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27364960     DOI: 10.1016/j.it.2016.06.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  14 in total

1.  Gene-enhancer variants reveal diverse TCR-mediated differentiation.

Authors:  Michael P Gallagher; Leslie J Berg
Journal:  Nat Immunol       Date:  2017-04-18       Impact factor: 25.606

2.  Lymphocytic division clocked up by Myc.

Authors:  Amir Erez; Grégoire Altan-Bonnet
Journal:  Immunol Cell Biol       Date:  2016-12-20       Impact factor: 5.126

3.  Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Authors:  Osmarie Martínez; Ariana Bravo Cruz; Saritza Santos; Maite Ramírez; Eric Miranda; Joanna Shisler; Miguel Otero
Journal:  Vaccine       Date:  2017-06-16       Impact factor: 3.641

Review 4.  Solving Immunology?

Authors:  Yoram Vodovotz; Ashley Xia; Elizabeth L Read; Josep Bassaganya-Riera; David A Hafler; Eduardo Sontag; Jin Wang; John S Tsang; Judy D Day; Steven H Kleinstein; Atul J Butte; Matthew C Altman; Ross Hammond; Stuart C Sealfon
Journal:  Trends Immunol       Date:  2016-12-13       Impact factor: 16.687

Review 5.  Lighting Up T Lymphocyte Signaling with Quantitative Phosphoproteomics.

Authors:  Candelas Álvarez-Salamero; Raquel Castillo-González; María N Navarro
Journal:  Front Immunol       Date:  2017-08-09       Impact factor: 7.561

6.  Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex.

Authors:  Arifumi Iwata; Vivek Durai; Roxane Tussiwand; Carlos G Briseño; Xiaodi Wu; Gary E Grajales-Reyes; Takeshi Egawa; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2017-03-27       Impact factor: 25.606

7.  A Stretch of Negatively Charged Amino Acids of Linker for Activation of T-Cell Adaptor Has a Dual Role in T-Cell Antigen Receptor Intracellular Signaling.

Authors:  Mikel M Arbulo-Echevarria; Isaac Narbona-Sánchez; Cecilia M Fernandez-Ponce; Inmaculada Vico-Barranco; Mª Dolores Rueda-Ygueravide; Michael L Dustin; Arkadiusz Miazek; Mª Carmen Duran-Ruiz; Francisco García-Cózar; Enrique Aguado
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

8.  Termination of T cell priming relies on a phase of unresponsiveness promoting disengagement from APCs and T cell division.

Authors:  Armelle Bohineust; Zacarias Garcia; Hélène Beuneu; Fabrice Lemaître; Philippe Bousso
Journal:  J Exp Med       Date:  2018-03-27       Impact factor: 14.307

Review 9.  Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes.

Authors:  Christopher Kopan; Tori Tucker; Michael Alexander; M Rezaa Mohammadi; Egest J Pone; Jonathan Robert Todd Lakey
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

Review 10.  Modes of Communication between T Cells and Relevance for Immune Responses.

Authors:  Lion F K Uhl; Audrey Gérard
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.